Finding from Washington University could hold key to more targeted breast cancer treatments
Researchers at Washington University have uncovered a genetic mutation that explains why some women don't respond to a common form of breast cancer treatment.
Before surgery, most women with breast cancer receive aromatase inhibitors, which reduce the production of estrogen to shrink the size of tumors. But it doesn't always work.
St. Louis Public Radio is a service of the University of Missouri-St. Louis.